DXCM — DEXCOM INC

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1093557 ·
Last close
$86.62
Market Cap
$32.69B
52W High
$92.59
52W Low
$54.11
ADV30
4,138,743
Next earnings
2026-10-29

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 1,308,400,000 830,000,000 318,300,000 249,100,000 6,455,300,000 1,105,000,000 3,833,900,000
Mar 2026 1,191,900,000 750,300,000 255,300,000 199,500,000 6,633,300,000 1,118,200,000 3,676,400,000
Dec 2025 1,259,600,000 792,700,000 323,000,000 267,300,000 6,339,900,000 917,700,000 3,593,900,000
Sep 2025 1,209,300,000 731,400,000 242,500,000 283,800,000 7,500,000,000 1,835,700,000 4,773,900,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,748,700,000
Investing CF
$530,700,000
Financing CF
$-2,329,500,000
CapEx
$-343,700,000
Dividends Paid
—
Buybacks
$-500,000,000
EPS Diluted TTM
$2.53
As of
2026-08-02

Balance + Analyst (yfinance extras)

Retained Earnings
$2,882,500,000
Inventory
$726,400,000
Receivables
$1,283,200,000
ST Investments
$842,000,000
EBIT TTM
$1,295,000,000
Pretax Income TTM
$1,280,000,000
Interest Exp TTM
$15,000,000
Analysts
25

Yahoo Snapshot (yfinance, live)

Total Revenue
$4,969,200,128
EBITDA
$1,403,200,000
Free Cash Flow
$1,021,162,496
Enterprise Value
$30,783,664,128
Total Cash
$1,947,000,064
Total Debt
$1,398,400,000
Shares Out
377,360,765
Trailing EPS
$2.53
Book Value
$6.95
ROE
38.5%
ROA
10.3%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 4,662,000,000 911,800,000 836,300,000 6,339,900,000 3,593,900,000 2,746,000,000 1,440,700,000
Dec 2024 4,033,000,000 600,000,000 576,200,000 6,484,500,000 4,381,900,000 2,102,600,000 989,500,000
Dec 2023 3,622,300,000 597,700,000 541,500,000 6,264,500,000 4,195,900,000 2,068,600,000 748,500,000
Dec 2022 2,909,800,000 391,200,000 341,200,000 5,391,700,000 3,259,900,000 2,131,800,000 669,500,000

TTM Snapshot

Revenues TTM
$3,774,800,000
NetIncome TTM
$461,900,000
OpCashFlow TTM
$0
Assets (Latest)
$6,339,900,000
Forward EPS
$3.12

Max Pain — expiry 2026-12-18

max pain strike: $80.00 · spot: $86.62 · call oi: 7,976 · put oi: 4,222
Expected Move to 2026-12-18: ±$15.45 (17.84%) — implied range $71.17 – $102.07 · ATM straddle on $85.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
RMD RESMED INC $32.02B $222.00 —
FSNUF Fresenius SE & Co. KGaA $30.61B $54.35 —
MDLN Medline Inc. $30.44B $34.70 —
GEHC GE HealthCare Technologies Inc. $30.10B $66.63 —
FSNUY Fresenius SE & Co. KGaA $29.92B $13.28 —

News headlines (Yahoo Finance, 1h cache)

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care
2026-09-28 06:00 · Yahoo
Is DexCom (DXCM) Cheap After Its Leadership Reshuffle Or Already Fairly Priced?
2026-09-24 04:29 · Yahoo
DexCom (DXCM) Promotes Former CFO Jereme Sylvain To Chief Operating Officer
2026-09-23 22:13 · Yahoo
Global Wearable Biosensors Market Trends, Strategies and Forecast to 2036 Featuring Abbott Labs, Dexcom, Medtronic, Roche, Apple, Samsung Electronics Co., Garmin and Other Key Players
2026-09-21 09:04 · Yahoo
Dexcom gives CFO Jereme Sylvain expanded role
2026-09-16 03:33 · Yahoo
Dexcom Promotes Jereme Sylvain to Chief Operating Officer
2026-09-14 20:30 · Yahoo
Dexcom Appoints Glenn Boehnlein to Board of Directors
2026-09-10 20:15 · Yahoo
DexCom Stock: Is DXCM Underperforming the Healthcare Sector?
2026-09-08 12:36 · Yahoo
Q2 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks
2026-09-03 19:27 · Yahoo
Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services
2026-09-03 05:51 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.